/
/
/

Morepen Laboratories Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
16%16%5%7%
49%29%5%22%
17%16%45%135%
14%16%10%12%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
MOREPENLAB
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,899.5₹456833 Cr37.7712.0762.82₹11479 Cr
9,134₹245426 Cr83.9134.04128.41₹2568 Cr
4,840₹187320 Cr85.8916.7297.06₹2163 Cr
1,129.5₹113217 Cr25.099.4262.53₹5040 Cr
1,380.1₹112212 Cr33.299.7757.87₹3879 Cr
1,843.1₹101155 Cr92.526.829.25₹889 Cr
2,109.6₹97626 Cr17.6630.95154.36₹5333 Cr
2,330.9₹96859 Cr47.4213.7571.08₹1913 Cr
1,157.5₹96406 Cr29.925.3263.99₹4196 Cr
1,653.4₹93614 Cr25.2217.9596.84₹3505 Cr
113.8₹6433 Cr45.781.033.22₹96 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2011Mar 2010Mar 2009Mar 2008Mar 2006
₹570 Cr₹485 Cr₹484 Cr₹412 Cr₹425 Cr₹466 Cr₹453 Cr₹438 Cr₹455 Cr₹423 Cr₹445 Cr₹422 Cr₹401 Cr₹364 Cr₹348 Cr₹403 Cr₹302 Cr₹368 Cr₹397 Cr₹395 Cr₹387 Cr₹287 Cr₹307 Cr₹336 Cr₹258 Cr₹207 Cr₹230 Cr₹213 Cr₹203 Cr₹219 Cr₹212 Cr₹174 Cr₹164 Cr₹171 Cr₹155 Cr₹150 Cr₹131 Cr₹60 Cr₹51 Cr₹44 Cr₹39 Cr₹37 Cr
₹5 Cr₹8 Cr₹4 Cr₹5 Cr₹4 Cr₹5 Cr₹5 Cr₹5 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹2 Cr₹3 Cr₹1 Cr₹87 L₹91 L₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹3 Cr₹4 Cr₹1 Cr₹2 Cr₹5 Cr₹3 Cr₹28 L₹1 Cr₹2 Cr₹13 L₹8 L₹30 L₹1 Cr₹86 L₹1 Cr₹0₹0₹0₹38 L₹4 L
₹575 Cr₹493 Cr₹488 Cr₹416 Cr₹430 Cr₹470 Cr₹458 Cr₹443 Cr₹459 Cr₹427 Cr₹449 Cr₹425 Cr₹403 Cr₹367 Cr₹350 Cr₹404 Cr₹303 Cr₹371 Cr₹399 Cr₹398 Cr₹388 Cr₹291 Cr₹310 Cr₹340 Cr₹259 Cr₹208 Cr₹235 Cr₹216 Cr₹203 Cr₹220 Cr₹215 Cr₹174 Cr₹164 Cr₹172 Cr₹156 Cr₹151 Cr₹132 Cr₹60 Cr₹51 Cr₹44 Cr₹40 Cr₹37 Cr
₹496 Cr₹466 Cr₹448 Cr₹392 Cr₹410 Cr₹440 Cr₹422 Cr₹396 Cr₹409 Cr₹384 Cr₹402 Cr₹396 Cr₹383 Cr₹355 Cr₹335 Cr₹381 Cr₹295 Cr₹356 Cr₹371 Cr₹360 Cr₹350 Cr₹263 Cr₹285 Cr₹312 Cr₹239 Cr₹196 Cr₹223 Cr₹207 Cr₹195 Cr₹208 Cr₹205 Cr₹167 Cr₹161 Cr₹164 Cr₹145 Cr₹138 Cr₹129 Cr₹70 Cr₹62 Cr₹52 Cr₹52 Cr₹50 Cr
₹88 Cr₹33 Cr₹50 Cr₹35 Cr₹29 Cr₹47 Cr₹41 Cr₹49 Cr₹55 Cr₹53 Cr₹55 Cr₹37 Cr₹29 Cr₹19 Cr₹22 Cr₹30 Cr₹15 Cr₹22 Cr₹35 Cr₹45 Cr₹45 Cr₹35 Cr₹33 Cr₹35 Cr₹28 Cr₹21 Cr₹20 Cr₹18 Cr₹20 Cr₹23 Cr₹19 Cr₹17 Cr₹12 Cr₹18 Cr₹19 Cr₹20 Cr₹11 Cr₹2 Cr₹1 Cr₹6 Cr₹56 L₹3 Cr
₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹1 Cr₹1 Cr₹1 Cr₹80 L₹2 Cr₹46 L₹28 L₹56 L₹55 L₹47 L₹40 L₹80 L₹75 L-₹9 Cr₹21 L-₹5 L₹1 Cr₹29 L₹29 L₹62 L₹54 L₹39 L₹43 L₹93 L₹43 L₹32 L₹44 L₹81 L₹91 L₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹64 L₹4 L₹15 L
₹75 Cr₹23 Cr₹35 Cr₹46 Cr₹16 Cr₹26 Cr₹35 Cr₹46 Cr₹48 Cr₹42 Cr₹44 Cr₹29 Cr₹21 Cr₹11 Cr₹14 Cr₹22 Cr₹8 Cr₹14 Cr₹27 Cr₹47 Cr₹39 Cr₹28 Cr₹24 Cr₹28 Cr₹20 Cr₹11 Cr₹11 Cr₹9 Cr₹8 Cr₹11 Cr₹9 Cr₹7 Cr₹3 Cr₹7 Cr₹10 Cr₹11 Cr₹1 Cr-₹12 Cr-₹13 Cr-₹8 Cr-₹13 Cr-₹13 Cr
₹56 Cr₹16 Cr₹27 Cr₹41 Cr₹11 Cr₹20 Cr₹27 Cr₹35 Cr₹36 Cr₹29 Cr₹32 Cr₹21 Cr₹15 Cr₹8 Cr₹9 Cr₹16 Cr₹6 Cr₹12 Cr₹22 Cr₹37 Cr₹30 Cr₹27 Cr₹24 Cr₹27 Cr₹19 Cr₹11 Cr₹11 Cr₹4 Cr₹8 Cr₹10 Cr₹9 Cr₹7 Cr₹2 Cr₹7 Cr₹10 Cr₹11 Cr₹1 Cr-₹11 Cr-₹13 Cr-₹77 L-₹4 Cr-₹9 Cr

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
₹110 Cr₹102 Cr₹102 Cr₹96 Cr₹90 Cr₹90 Cr₹90 Cr₹90 Cr₹90 Cr₹210 Cr₹210 Cr₹210 Cr₹210 Cr₹210 Cr₹210 Cr₹210 Cr₹191 Cr₹191 Cr₹65 Cr
₹0₹0₹0₹26 Cr₹44 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹3 Cr₹3 Cr₹137 Cr
₹1047 Cr₹745 Cr₹651 Cr₹457 Cr₹291 Cr₹194 Cr₹163 Cr₹136 Cr₹106 Cr₹91 Cr₹78 Cr₹88 Cr₹90 Cr₹111 Cr₹134 Cr₹181 Cr₹99 Cr₹147 Cr₹39 Cr
₹1047 Cr₹745 Cr₹651 Cr₹457 Cr₹291 Cr₹194 Cr₹163 Cr₹136 Cr₹106 Cr₹91 Cr₹78 Cr₹88 Cr₹90 Cr₹111 Cr₹134 Cr₹181 Cr₹99 Cr₹147 Cr₹39 Cr
₹1156 Cr₹847 Cr₹753 Cr₹579 Cr₹425 Cr₹284 Cr₹253 Cr₹226 Cr₹196 Cr₹300 Cr₹287 Cr₹297 Cr₹300 Cr₹320 Cr₹344 Cr₹391 Cr₹293 Cr₹341 Cr₹241 Cr
₹31 Cr₹0-₹46 L-₹46 L-₹46 L-₹46 L-₹46 L-₹45 L-₹63 L-₹63 L-₹40 L-₹40 L-₹43 L-₹42 L-₹44 L-₹44 L-₹36 L-₹29 L-₹29 L
₹6 Cr₹3 Cr₹93 L₹1 Cr₹83 L₹92 L₹2 Cr₹3 Cr₹1 Cr₹43 Cr₹62 Cr₹75 Cr₹95 Cr₹99 Cr₹114 Cr₹128 Cr₹137 Cr₹144 Cr₹304 Cr
₹20 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹15 Cr₹14 Cr₹11 Cr₹144 Cr₹148 Cr₹194 Cr
₹7 Cr₹2 Cr₹3 Cr₹2 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹18 Cr₹5 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹0₹0₹0₹0
₹40 Cr₹34 Cr₹30 Cr₹28 Cr₹25 Cr₹24 Cr₹19 Cr₹14 Cr₹14 Cr₹11 Cr₹9 Cr₹8 Cr₹7 Cr₹6 Cr₹4 Cr₹0₹0₹0₹0
₹90 Cr₹44 Cr₹37 Cr₹35 Cr₹30 Cr₹28 Cr₹23 Cr₹20 Cr₹18 Cr₹57 Cr₹74 Cr₹85 Cr₹104 Cr₹122 Cr₹135 Cr₹140 Cr₹280 Cr₹292 Cr₹498 Cr
₹363 Cr₹295 Cr₹227 Cr₹258 Cr₹209 Cr₹172 Cr₹168 Cr₹175 Cr₹125 Cr₹115 Cr₹85 Cr₹69 Cr₹57 Cr₹65 Cr₹60 Cr₹82 Cr₹78 Cr₹71 Cr₹70 Cr
₹72 Cr₹59 Cr₹55 Cr₹170 Cr₹174 Cr₹165 Cr₹161 Cr₹164 Cr₹199 Cr₹47 Cr₹40 Cr₹38 Cr₹45 Cr₹39 Cr₹41 Cr₹0₹11 L₹25 L₹87 L
₹46 Cr₹23 Cr₹23 Cr₹16 Cr₹15 Cr₹11 Cr₹9 Cr₹0₹0₹0₹2 Cr₹1 Cr₹0₹0₹0₹0₹0₹0₹0
₹20 Cr₹25 Cr₹16 Cr₹12 Cr₹5 Cr₹3 Cr₹1 Cr₹1 Cr₹1 Cr₹4 Cr₹86 L₹77 L₹70 L₹1 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr
₹501 Cr₹402 Cr₹321 Cr₹456 Cr₹404 Cr₹351 Cr₹339 Cr₹340 Cr₹325 Cr₹167 Cr₹128 Cr₹108 Cr₹103 Cr₹105 Cr₹103 Cr₹85 Cr₹81 Cr₹73 Cr₹73 Cr
₹1778 Cr₹1293 Cr₹1111 Cr₹1070 Cr₹858 Cr₹663 Cr₹615 Cr₹586 Cr₹538 Cr₹524 Cr₹489 Cr₹490 Cr₹506 Cr₹547 Cr₹581 Cr₹616 Cr₹653 Cr₹706 Cr₹811 Cr
₹18 Cr₹10 Cr₹7 Cr₹3 Cr₹93 L₹1 Cr₹12 Cr₹26 Cr₹32 Cr₹28 Cr₹33 Cr₹33 Cr₹35 Cr₹13 Cr₹5 Cr₹4 Cr₹85 Cr₹20 Cr₹25 Cr
₹79 Cr₹29 Cr₹25 Cr₹19 Cr₹17 Cr₹13 Cr₹132 Cr₹15 Cr₹49 Cr₹68 Cr₹81 Cr₹89 Cr₹111 Cr₹121 Cr₹133 Cr₹140 Cr₹280 Cr₹292 Cr₹498 Cr
₹828 Cr₹621 Cr₹656 Cr₹613 Cr₹628 Cr₹753 Cr₹888 Cr₹998 Cr₹1027 Cr₹1018 Cr₹1009 Cr₹1005 Cr₹1000 Cr₹997 Cr₹998 Cr₹996 Cr₹991 Cr₹1003 Cr₹1002 Cr
₹340 Cr₹313 Cr₹389 Cr₹361 Cr₹404 Cr₹536 Cr₹652 Cr₹733 Cr₹755 Cr₹722 Cr₹687 Cr₹637 Cr₹591 Cr₹546 Cr₹502 Cr₹455 Cr₹408 Cr₹365 Cr₹317 Cr
₹489 Cr₹307 Cr₹267 Cr₹252 Cr₹225 Cr₹216 Cr₹236 Cr₹264 Cr₹272 Cr₹297 Cr₹322 Cr₹368 Cr₹409 Cr₹452 Cr₹496 Cr₹540 Cr₹583 Cr₹638 Cr₹686 Cr
₹28 Cr₹24 Cr₹17 Cr₹14 Cr₹2 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹7 Cr₹1 Cr₹0₹0₹1 Cr₹1 Cr₹0₹0₹0₹0₹0₹0₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
₹7 Cr₹1 Cr₹0₹0₹1 Cr₹1 Cr₹0₹0₹0₹0₹0₹0₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
₹94 Cr₹71 Cr₹70 Cr₹70 Cr₹104 Cr₹74 Cr₹79 Cr₹78 Cr₹74 Cr₹70 Cr₹52 Cr₹25 Cr₹2 Cr₹2 Cr₹1 Cr₹0₹0₹0₹0
₹23 L₹24 L₹28 L₹28 L₹27 L₹28 L₹28 L₹27 L₹85 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹619 Cr₹404 Cr₹354 Cr₹336 Cr₹331 Cr₹291 Cr₹316 Cr₹342 Cr₹346 Cr₹367 Cr₹374 Cr₹393 Cr₹415 Cr₹457 Cr₹501 Cr₹544 Cr₹587 Cr₹642 Cr₹690 Cr
₹78 Cr₹0₹0₹0₹0₹0₹2 L₹22 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹300 Cr₹249 Cr₹229 Cr₹276 Cr₹175 Cr₹138 Cr₹94 Cr₹77 Cr₹65 Cr₹42 Cr₹37 Cr₹33 Cr₹37 Cr₹39 Cr₹35 Cr₹32 Cr₹22 Cr₹19 Cr₹18 Cr
₹325 Cr₹325 Cr₹263 Cr₹251 Cr₹182 Cr₹138 Cr₹134 Cr₹122 Cr₹93 Cr₹88 Cr₹56 Cr₹43 Cr₹39 Cr₹35 Cr₹30 Cr₹24 Cr₹21 Cr₹13 Cr₹10 Cr
₹49 Cr₹52 Cr₹56 Cr₹46 Cr₹68 Cr₹39 Cr₹32 Cr₹6 Cr₹8 Cr₹4 Cr₹9 Cr₹9 Cr₹6 Cr₹5 Cr₹3 Cr₹1 Cr₹5 Cr₹15 Cr₹68 Cr
₹72 Cr₹16 Cr₹7 Cr₹5 Cr₹10 Cr₹6 Cr₹8 Cr₹5 Cr₹3 Cr₹5 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr₹4 Cr
₹336 Cr₹247 Cr₹201 Cr₹157 Cr₹92 Cr₹51 Cr₹31 Cr₹34 Cr₹23 Cr₹17 Cr₹10 Cr₹8 Cr₹7 Cr₹10 Cr₹10 Cr₹11 Cr₹15 Cr₹9 Cr₹8 Cr
₹1159 Cr₹889 Cr₹756 Cr₹734 Cr₹527 Cr₹372 Cr₹299 Cr₹243 Cr₹192 Cr₹157 Cr₹115 Cr₹96 Cr₹91 Cr₹90 Cr₹80 Cr₹70 Cr₹65 Cr₹60 Cr₹109 Cr
₹659 Cr₹487 Cr₹435 Cr₹278 Cr₹123 Cr₹21 Cr-₹40 Cr-₹97 Cr-₹133 Cr-₹9 Cr-₹13 Cr-₹12 Cr-₹12 Cr-₹15 Cr-₹23 Cr-₹15 Cr-₹16 Cr-₹13 Cr₹37 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹1 Cr₹1 Cr₹5 Cr₹12 Cr
₹1778 Cr₹1293 Cr₹1111 Cr₹1070 Cr₹858 Cr₹663 Cr₹615 Cr₹586 Cr₹538 Cr₹524 Cr₹489 Cr₹490 Cr₹506 Cr₹547 Cr₹581 Cr₹616 Cr₹653 Cr₹706 Cr₹811 Cr
₹21₹17₹15₹12₹8₹6₹6₹5₹4₹4₹4₹4₹4₹4₹5₹6₹5₹6₹3
₹21₹17₹15₹12₹8₹6₹6₹5₹4₹4₹4₹4₹4₹4₹5₹6₹5₹6₹3

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
₹155 Cr₹135 Cr₹56 Cr₹127 Cr₹99 Cr₹39 Cr₹29 Cr₹30 Cr₹23 Cr₹17 Cr₹2 Cr-₹6 Cr-₹24 Cr-₹36 Cr-₹48 Cr-₹40 Cr-₹49 Cr-₹68 Cr-₹48 Cr
₹38 Cr₹34 Cr₹28 Cr₹19 Cr₹32 Cr₹37 Cr₹40 Cr₹39 Cr₹41 Cr₹46 Cr₹47 Cr₹56 Cr₹57 Cr₹56 Cr₹54 Cr₹52 Cr₹54 Cr₹67 Cr₹56 Cr
-₹124 Cr-₹58 Cr-₹158 Cr-₹181 Cr-₹78 Cr-₹59 Cr-₹52 Cr-₹5 Cr-₹24 Cr-₹8 Cr₹1 Cr-₹20 Cr-₹3 Cr-₹5 Cr₹4 Cr-₹5 Cr-₹8 Cr-₹3 Cr₹347 Cr
₹69 Cr₹111 Cr-₹75 Cr-₹35 Cr₹52 Cr₹17 Cr₹18 Cr₹63 Cr₹41 Cr₹54 Cr₹51 Cr₹31 Cr₹31 Cr₹15 Cr₹10 Cr₹7 Cr-₹3 Cr-₹4 Cr₹355 Cr
₹32 Cr₹73 Cr-₹91 Cr-₹60 Cr₹51 Cr₹11 Cr₹17 Cr₹63 Cr₹41 Cr₹50 Cr₹51 Cr₹34 Cr₹34 Cr₹27 Cr₹11 Cr₹7 Cr-₹3 Cr₹8 Cr₹270 Cr
-₹322 Cr-₹83 Cr-₹47 Cr-₹32 Cr-₹70 Cr-₹12 Cr-₹13 Cr-₹27 Cr-₹14 Cr-₹27 Cr-₹32 Cr-₹80 L-₹3 Cr-₹3 Cr-₹4 Cr-₹4 Cr-₹1 Cr-₹72 L₹8 Cr
₹300 Cr₹5 Cr₹144 Cr₹66 Cr₹47 Cr₹5 Cr-₹44 L-₹38 Cr-₹24 Cr-₹27 Cr-₹19 Cr-₹29 Cr-₹30 Cr-₹22 Cr-₹6 Cr-₹6 Cr-₹6 Cr-₹61 Cr-₹281 Cr
₹10 Cr-₹5 Cr₹6 Cr-₹26 Cr₹28 Cr₹4 Cr₹4 Cr-₹1 Cr₹3 Cr-₹4 Cr-₹26 L₹4 Cr₹1 Cr₹2 Cr₹1 Cr-₹3 Cr-₹11 Cr-₹53 Cr-₹3 Cr
₹17 Cr₹22 Cr₹16 Cr₹41 Cr₹14 Cr₹10 Cr₹6 Cr₹7 Cr₹4 Cr₹9 Cr₹9 Cr₹6 Cr₹5 Cr₹3 Cr₹1 Cr₹5 Cr₹15 Cr₹68 Cr₹71 Cr
₹27 Cr₹17 Cr₹22 Cr₹16 Cr₹41 Cr₹14 Cr₹10 Cr₹6 Cr₹7 Cr₹4 Cr₹9 Cr₹9 Cr₹6 Cr₹5 Cr₹3 Cr₹1 Cr₹5 Cr₹15 Cr₹68 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)117.91
Volume (₹)1.45 Cr
High (₹)118.00
Upper Circuit129.19
Low (₹)112.55
Lower Circuit105.71
Prev Close117.45
52W High (₹)118.55
Price113.80
52W Low (₹)33.05

Share Market Cap & Key Ratios Overview

M.Cap (₹)6432.98 Cr
Div. Yield (%)0.17
PE Ratio45.78
Debt to Equity0.07
Price to Book2.27
Book Value21.10
EPS (TTM)2.56
Face Value2.00
ROE (%)11.78

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
MOREPENLABNSE
LTP
1W Low
1W High
Market cap (₹)
1899.5-20.5 (-1.07%)
1896.80
1984.80
4,56,833Cr
9134-105 (-1.14%)
9087
9467
2,45,426Cr
4840-210 (-4.16%)
4823
5066
1,87,320Cr
1129.5-61.5 (-5.16%)
1125.10
1187
1,13,217Cr
1380.1-43.4 (-3.05%)
1376
1426.10
1,12,212Cr
1843.1-95.4 (-4.92%)
1811.70
1949
1,01,155Cr
2109.6-61.9 (-2.85%)
2107.20
2192
97,626Cr
2330.9-52 (-2.18%)
2327.30
2419.20
96,859Cr
1157.5-20.5 (-1.74%)
1154.40
1179.90
96,406Cr
1653.4+8.1 (0.49%)
1622.60
1717
93,614Cr
113.8+7.61 (7.17%)
100.10
118.55
6,433Cr

Morepen Laboratories Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹87.72Cr; with other income of ₹5.18Cr, profit before interest and tax came to ₹79.37Cr. Interest expense was ₹4.84Cr; PBT before exceptional items stood at ₹74.53Cr. Cost mix (full year): raw materials ₹1160.23Cr; employee cost ₹208.91Cr; depreciation ₹8.35Cr; other expenses ₹487.59Cr. Basis: consolidated annual results.

Morepen Laboratories Ltd Quaterly Results Key Takeaways

Morepen Laboratories Ltd reported ₹570.13Cr total income from operations in Jun 2026, softer than ₹484.72Cr in Mar 2026 but higher than ₹425.24Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹87.72Cr; with other income of ₹5.18Cr, profit before interest and tax came to ₹79.37Cr. Interest expense was ₹4.84Cr, taking profit before tax to ₹74.53Cr. After tax of ₹18.18Cr, profit after tax stood at ₹56.35Cr (vs ₹15.7Cr in Mar 2026 and ₹11.4Cr in Jun 2025).